Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 1
Submit an article Journal homepage
309
Views
33
CrossRef citations to date
0
Altmetric
Original

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

Myron S. Czuczman Roswell Park Cancer Institute, Buffalo, NY, USACorrespondence[email protected]
, MD,
Pierluigi Porcu The Ohio State University Medical Center, Columbus, OH, USA
,
Jeffrey Johnson CALGB Statistical Center, Durham, NC, USA
,
Donna Niedzwiecki CALGB Statistical Center, Durham, NC, USA
,
Michael Kelly CALGB Statistical Center, Durham, NC, USA
,
Eric D. Hsi Cleveland Clinic, Cleveland, OH, USA
,
James R Cook Cleveland Clinic, Cleveland, OH, USA
,
George Canellos Dana Farber Cancer Institute, Boston, MA, USA
,
Bruce D. Cheson Georgetown University Hospital, Washington, DC, USA
&
For the Cancer and Leukemia Group B Roswell Park Cancer Institute, Buffalo, NY, USA
 show all
Pages 97-103 | Received 16 Nov 2005, Accepted 15 Aug 2006, Published online: 01 Jul 2009

References

  • Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
  • Melnyk A, Rodriguez A, Pugh W C, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514–4520
  • Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76–82
  • Evens A M, Gartenhaus R B. Treatment of T-cell non-Hodgkin's lymphoma. Curr Treat Options Oncol 2004; 5: 289–303
  • Lundin J, Osterborg A. Therapy for mycosis fungoides. Curr Treat Options Oncol 2004; 5: 203–214
  • Carson D A, Kaye J, Matsumoto S, Seegmiller J E, Thompson L. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proc Natl Acad Sci USA 1979; 76: 2430–2433
  • Shewach D S, Daddona P E, Ashcraft E, Mitchell B S. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. Cancer Res 1985; 45: 1008–1014
  • Berg S L, Blaney S M, Devidas M, Lampkin T A, Murgo A, Bernstein M, et al. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. J Clin Oncol 2005; 23: 3376–3382
  • Kurtzberg J, Ernst T J, Keating M J, Gandhi V, Hodge J P, Kisor D F, et al. Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol 2005; 23: 3396–3403
  • Gandhi V, Plunkett W, Rodriguez C O, Jr, Nowak B J, Du M, Ayres M, et al. Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. J Clin Oncol 1998; 16: 3607–3615

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.